Live Breaking News & Updates on Steven Favaloro

Stay updated with breaking news from Steven favaloro. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Genezen lands $18.5 million growth investment – Inside INdiana Business

Genezen lands $18.5 million growth investment – Inside INdiana Business
insideindianabusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insideindianabusiness.com Daily Mail and Mail on Sunday newspapers.

Indiana , United-states , Crosspoint-business-park , Alex-brown , Steven-favaloro , David-anderson , Boston-based-ampersand-capital , Ampersand-capital-partners-general-partner-david , Launch-fishers , Crosspoint-business ,

Genezen Secures $18.5 Million in Growth Equity to Expand Viral Vector Development and Manufacturing Capabilities

/PRNewswire/ Genezen, a leading cell and gene therapy Contract Development and Manufacturing Organization (CDMO), today announced the closing of an $18.5. ....

Indiana , United-states , Amsterdam , Noord-holland , Netherlands , Boston , Massachusetts , Connor-halverson , Steven-favaloro , Prnewswire-genezen , David-anderson , Contract-development

Fishers-based gene therapy firm Genezen appoints new CEO – Indianapolis Business Journal

Steven J. Favaloro brings a background in finance in the life sciences industry to his new positions as president and CEO. ....

Boston , Massachusetts , United-states , Australia , Cambridge , Cambridgeshire , United-kingdom , Watertown , Australian , Brammer-bio , Steven-favaloro , Stevenj-favaloro

Arranta Bio Announces Addition of 130,000 sq. ft. Boxborough, Mass., Manufacturing Facility to Supply Clinical and Commercial Microbiome Products for Clients and closes Series B Equity Financing


Share this article
Share this article
WATERTOWN, Mass., March 8, 2021 /PRNewswire/ Arranta Bio ( Arranta ), the leading microbiome contract development and manufacturing organization (CDMO), today announced the addition of a 130,000-square-foot facility in Boxborough, Massachusetts, to complement its existing facilities in Watertown, Massachusetts and Gainesville, Florida, bringing the total manufacturing capacity at Arranta to over 230,000 square feet. Arranta closed an oversubscribed Series B equity financing from its current investors to fund the expansion.
(PRNewsfoto/Arranta Bio)
The Boxborough site will be developed in phases, and work on the first two phases has begun. Total investment in Boxborough is expected to exceed $150 million, and with the first phases of construction underway, start-up of GMP suites is expected early in 2022. The facility will employ more than 250 people, and is designed to flexibly support clients, including dedicated lab and GM ....

Boston , Massachusetts , United-states , Watertown , Amsterdam , Noord-holland , Netherlands , David-stevens , Steven-favaloro , Weigao , Arranta-bio , Mark-bamforth

Arranta Bio Announces Addition of 130,000 sq. ft. Boxborough, Mass., Manufacturing Facility to Supply Clinical and Commercial Microbiome Products for Clients and closes Series B Equity Financing

Arranta Bio Announces Addition of 130,000 sq. ft. Boxborough, Mass., Manufacturing Facility to Supply Clinical and Commercial Microbiome Products for Clients and closes Series B Equity Financing
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Boston , Massachusetts , United-states , Watertown , Amsterdam , Noord-holland , Netherlands , David-stevens , Steven-favaloro , Wei-gao , Arranta-bio , Mark-bamforth